Search

Dameron Levest Jones

Examiner (ID: 18762, Phone: (571)272-0617 , Office: P/1618 )

Most Active Art Unit
1618
Art Unit(s)
1621, 1616, 3991, 1211, 1618, RD00, 1619, 1622, 1615
Total Applications
2574
Issued Applications
1523
Pending Applications
392
Abandoned Applications
685

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11756045 [patent_doc_number] => 20170202912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA' [patent_app_type] => utility [patent_app_number] => 15/471992 [patent_app_country] => US [patent_app_date] => 2017-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 27724 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471992 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/471992
OPTOGENETIC CONTROL OF INPUTS TO THE VENTRAL TEGMENTAL AREA Mar 27, 2017 Abandoned
Array ( [id] => 11962131 [patent_doc_number] => 20170266285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED HEMOGLOBIN-BASED THERAPEUTIC AGENT FOR CANCER TARGETING TREATMENT AND DIAGNOSTIC IMAGING' [patent_app_type] => utility [patent_app_number] => 15/469978 [patent_app_country] => US [patent_app_date] => 2017-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 10299 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15469978 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/469978
Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging Mar 26, 2017 Issued
Array ( [id] => 17434830 [patent_doc_number] => 11260136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-03-01 [patent_title] => Radio-pharmaceutical complexes [patent_app_type] => utility [patent_app_number] => 16/087040 [patent_app_country] => US [patent_app_date] => 2017-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13079 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087040 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/087040
Radio-pharmaceutical complexes Mar 19, 2017 Issued
Array ( [id] => 14043545 [patent_doc_number] => 20190077879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-14 [patent_title] => CONJUGATES ENHANCING TOTAL CELLULAR ACCUMULATION [patent_app_type] => utility [patent_app_number] => 16/085141 [patent_app_country] => US [patent_app_date] => 2017-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7066 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/085141
Conjugates enhancing total cellular accumulation Mar 14, 2017 Issued
Array ( [id] => 11713692 [patent_doc_number] => 20170182192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE' [patent_app_type] => utility [patent_app_number] => 15/459078 [patent_app_country] => US [patent_app_date] => 2017-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2057 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15459078 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/459078
METHOD OF DRY DYE DELIVERY FOR STAINING THE EYE Mar 14, 2017 Abandoned
Array ( [id] => 13955597 [patent_doc_number] => 20190054142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA [patent_app_type] => utility [patent_app_number] => 16/079787 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16079787 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/079787
ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA Feb 23, 2017 Abandoned
Array ( [id] => 13955699 [patent_doc_number] => 20190054193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => ACTIVITY BASED PROBE AND USES THEREOF FOR IMAGING [patent_app_type] => utility [patent_app_number] => 16/077879 [patent_app_country] => US [patent_app_date] => 2017-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23797 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16077879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/077879
Activity based probe and uses thereof for imaging Feb 15, 2017 Issued
Array ( [id] => 12001813 [patent_doc_number] => 20170305968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE' [patent_app_type] => utility [patent_app_number] => 15/427427 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 43987 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427427 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/427427
PEPTIDES WHOSE UPTAKE IN CELLS IS CONTROLLABLE Feb 7, 2017 Abandoned
Array ( [id] => 12000316 [patent_doc_number] => 20170304471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'ANTICANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 15/427355 [patent_app_country] => US [patent_app_date] => 2017-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14484 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427355 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/427355
Anticancer therapy Feb 7, 2017 Issued
Array ( [id] => 11742922 [patent_doc_number] => 20170196995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'OPTICAL IMAGING PROBES' [patent_app_type] => utility [patent_app_number] => 15/413139 [patent_app_country] => US [patent_app_date] => 2017-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13421 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413139 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/413139
Optical imaging probes Jan 22, 2017 Issued
Array ( [id] => 16492371 [patent_doc_number] => 10858396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-08 [patent_title] => HER2 peptide regents and methods [patent_app_type] => utility [patent_app_number] => 15/780286 [patent_app_country] => US [patent_app_date] => 2016-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 97 [patent_no_of_words] => 14060 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780286 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/780286
HER2 peptide regents and methods Nov 30, 2016 Issued
Array ( [id] => 16930953 [patent_doc_number] => 20210196842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE [patent_app_type] => utility [patent_app_number] => 15/777558 [patent_app_country] => US [patent_app_date] => 2016-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24861 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777558 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/777558
SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE Nov 28, 2016 Abandoned
Array ( [id] => 18908935 [patent_doc_number] => 11871895 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-16 [patent_title] => Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo [patent_app_type] => utility [patent_app_number] => 15/778236 [patent_app_country] => US [patent_app_date] => 2016-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 5342 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15778236 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/778236
Raman spectroscopy reporters and methods for molecular imaging of tissue in vivo Nov 22, 2016 Issued
Array ( [id] => 13567775 [patent_doc_number] => 20180335435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => USE OF RECEPTOR-BINDING DOMAIN DERIVED FROM BOVINE LEUKEMIA VIRUS FOR THE DIAGNOSIS OR TREATMENT OF CATIONIC L-AMINO ACID TRANSPORTER-RELATED DISEASES [patent_app_type] => utility [patent_app_number] => 15/777087 [patent_app_country] => US [patent_app_date] => 2016-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15777087 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/777087
Use of receptor-binding domain derived from bovine leukemia virus for the diagnosis or treatment of cationic l-amino acid transporter-related diseases Nov 17, 2016 Issued
Array ( [id] => 13604159 [patent_doc_number] => 20180353628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => Labeled Probe and Methods of Use [patent_app_type] => utility [patent_app_number] => 15/775450 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11561 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775450 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/775450
Labeled probe and methods of use Nov 10, 2016 Issued
Array ( [id] => 13604157 [patent_doc_number] => 20180353627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS [patent_app_type] => utility [patent_app_number] => 15/775743 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10695 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775743 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/775743
RADIOLABELED DISINTEGRINS AS BRACHYTHERAPY AGENTS Nov 10, 2016 Abandoned
Array ( [id] => 11689666 [patent_doc_number] => 20170165382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-15 [patent_title] => 'NANOCARRIERS FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 15/349946 [patent_app_country] => US [patent_app_date] => 2016-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20241 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15349946 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/349946
NANOCARRIERS FOR CANCER TREATMENT Nov 10, 2016 Abandoned
Array ( [id] => 11671567 [patent_doc_number] => 20170160287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-08 [patent_title] => 'USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS' [patent_app_type] => utility [patent_app_number] => 15/347965 [patent_app_country] => US [patent_app_date] => 2016-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10993 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15347965 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/347965
USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS Nov 9, 2016 Abandoned
Array ( [id] => 11443059 [patent_doc_number] => 20170044080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-16 [patent_title] => 'RADIOCONJUGATION METHOD' [patent_app_type] => utility [patent_app_number] => 15/340743 [patent_app_country] => US [patent_app_date] => 2016-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9068 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15340743 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/340743
RADIOCONJUGATION METHOD Oct 31, 2016 Abandoned
Array ( [id] => 11647950 [patent_doc_number] => 20170143851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-05-25 [patent_title] => 'IMAGING AGENTS FOR IMAGING PROTEASE ACTIVITY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/337461 [patent_app_country] => US [patent_app_date] => 2016-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 13002 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337461 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/337461
Imaging agents for imaging protease activity and uses thereof Oct 27, 2016 Issued
Menu